Navigation Links
Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
Date:9/25/2013

Irvine, CA (PRWEB) September 25, 2013

Proove Biosciences Inc. (http://www.proovebio.com), the leading personalized pain medicine laboratory, announces that they will again be presenting research on the genetics of pain medicine at a major scientific meeting this year. This weekend, Proove will present preliminary findings from a clinical study during the poster session and will exhibit at the American Academy of Pain Management’s 24th Annual Clinical Meeting at the JW Marriott Orlando, Orlando, Florida. The event will be held from September 26th to September 29nd. Proove will be presenting research on the clinical and economic outcomes of using the Proove Narcotic Risk Genetics Test in the treatment and management of pain.

The American Academy of Pain Management is the one of largest pain management organizations in the nation and uniquely embraces an integrative model of care, which includes bringing together all appropriate therapeutic approaches and a team of clinicians to reduce pain and achieve optimal health and healing. The AAPM also offers continuing education, publications, and advocacy.

Proove Biosciences CEO, Brian Meshkin, states, “We are pleased to again have our research selected by experts in the field to be presented at another industry leading conference. The AAPM’s Annual Clinical Meeting bri
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
5. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
6. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
7. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
8. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
9. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
10. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
11. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Visual Assay ... and celebrate the top 100 most innovative technologies and services of the past year. ... named in the Software/Services category. The winners will be announced at the 2015 R&D ...
(Date:7/24/2015)... , July 24, 2015 Ryan & Maniskas, ... in United States District Court for the Northern District of ... or entities that purchased the common stock of Avalanche Biotechnologies, ... July 31, 2014 and June 15, 2015, inclusive (the "Class ... 8, 2015, move the Court for appointment as a lead ...
(Date:7/24/2015)... -- Champions Oncology (OTC-BB: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year quarter ended April ... open. The company will host a conference ... a.m. EDT (6:00 a.m. PDT). To participate in the ...
(Date:7/24/2015)... The global next generation ... billion by 2022, growing at an estimated CAGR of ... study by Grand View Research, Inc. Development of faster, ... in significant reduction in cost of sequencing one base ... rates of next generation sequencing throughout the forecast period. ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... MISSISSAUGA, ON, Sept. 23 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... results for its fiscal year end, ended June 30, ... for YM. Our most notable development was the merger ... completed in January, from which we gained two important ...
... Resources, one of the world,s leading research and ... that growth in the leukemia market will be ... (Novartis,s Gleevec and Tasigna and Bristol-Myers Squibb,s Sprycel) ... Rituxan and Cephalon,s Treanda) until 2015, when patent ...
... 23 Dr. Paul Greengard, a Nobel Prize-winning ... Alzheimer,s Disease Research at The Rockefeller University, will ... September 23rd, 2010.  This medal is the highest ... anniversary celebrations, and recognizes the work of an ...
Cached Biology Technology:YM BioSciences reports fiscal year end 2010 operational and financial results 2YM BioSciences reports fiscal year end 2010 operational and financial results 3YM BioSciences reports fiscal year end 2010 operational and financial results 4YM BioSciences reports fiscal year end 2010 operational and financial results 5YM BioSciences reports fiscal year end 2010 operational and financial results 6YM BioSciences reports fiscal year end 2010 operational and financial results 7YM BioSciences reports fiscal year end 2010 operational and financial results 8YM BioSciences reports fiscal year end 2010 operational and financial results 9YM BioSciences reports fiscal year end 2010 operational and financial results 10YM BioSciences reports fiscal year end 2010 operational and financial results 11Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon 2Dr. Paul Greengard, Karolinska Institutet's Bicentennial Gold Medal Recipient 2
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... THE HAGUE, The Netherlands -- Recognizing the strategic ... and become recognized research leaders in the underwater ... Stevens Institute of Technology recently entered into an ... Memorandum of Understanding (MOU) between the university and ...
... moms abandon their eggs before they hatch doesn,t mean ... research in the American Naturalist shows that ... threats. Researchers Jonathan Storm of the University of ... Indiana State University placed pregnant crickets into enclosures containing ...
... Recovery and Reinvestment Act (ARRA) the economic stimulus ... examples of how a relatively small element of the ... the nation. Of the $787 billion contained in ... science infrastructure. ScienceWorksForUS, a coalition of three associations ...
Cached Biology News:Stevens and TNO to collaborate on maritime security 2Study: Crickets 'forewarn' unborn babies about spiders 2Universities highlight benefits of stimulus research funding 2Universities highlight benefits of stimulus research funding 3
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
...
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Permeabilization Solution, 5X...
Biology Products: